In the IDEAL-LM study that included 818 patients undergoing LM PCI, a biodegradable-polymer everolimus-eluting stent followed by 4-month DAPT demonstrated noninferiority compared with a durable-polymer everolimus-eluting stent followed by 12 months of DAPT, although a numerical trend toward higher ischemic event rates was observed in the biodegradable polymer stent with the 4-month DAPT group [ 73 ].
← all excerpts
Antithrombotic Strategies After Complex Percutaneous Coronary Intervention.
1
—
—